Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
VIRACTA THERAPEUTICS INC
About VIRX
Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers, which impact patients worldwide. The Company’s lead product candidate is an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir (collectively, Nana-val). Nana-val is being evaluated in multiple ongoing clinical trials, including a pivotal, global, multicenter, open-label Phase II basket trial for the treatment of multiple subtypes of relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) lymphoma (NAVAL-1), as well as a multinational, open-label Phase Ib/II clinical trial for the treatment of patients with recurrent or metastatic (R/M) EBV + nasopharyngeal carcinoma (NPC) and other advanced EBV + solid tumors. The Company is also pursuing the application of its Kick and Kill approach in other virus-related cancers.
Find out what a historical investment in VIRACTA THERAPEUTICS INC would be worth today using our VIRX stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy VIRX shares in Australia?
Buying VIRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in VIRACTA THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in VIRX
What is the ticker symbol of VIRACTA THERAPEUTICS INC?
The ticker symbol for VIRACTA THERAPEUTICS INC is VIRX.
How much is one share of VIRX?
One share of VIRX is valued at $0.01 as of 20 May 2026.
What is the market capitalisation of VIRACTA THERAPEUTICS INC VIRX?
As of 20 May 2026 VIRACTA THERAPEUTICS INC has a market cap of -.
What is the 52-week high for VIRACTA THERAPEUTICS INC stock?
The VIRACTA THERAPEUTICS INC 52-week high stock price is $NaN.
What is the 52-week low for VIRACTA THERAPEUTICS INC stock?
The VIRACTA THERAPEUTICS INC 52-week low stock price is $NaN.
Can I buy VIRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VIRX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in VIRX on Stake
- Buy VIRX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of VIRX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
VIRX related stocks